Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. ACN
9. NVO
10. COHR

Go back to Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis
Pfizer Inc. (NYSE: PFE) Delayed: 27.74 +0.08 (0.29%)
Previous Close $27.66    52 Week High $37.39 
Open $27.65    52 Week Low $28.25 
Day High $27.92    P/E 16.81 
Day Low $27.53    EPS $1.65 
Volume 28,773,170